Chondroitin sulfate-cell membrane effectors as regulators of growth factor-mediated vascular and cancer cell migration

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 8, 2014, Pages 2643-2650

  Pantazaka, Evangelia ^a   Papadimitriou, Evangelia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiogenesis; Cell migration; Glycosaminoglycan; Glycosylation; Proteoglycan; Receptor protein tyrosine phosphatase

Indexed keywords

CHONDROITIN SULFATE; CHONDROITIN SULFATE PROTEOGLYCAN 4; GLUCURONIC ACID; GLYCOSAMINOGLYCAN; GROWTH FACTOR; INTEGRIN; N ACETYLGALACTOSAMINE; NEUROPILIN 1; NUCLEOLIN; PROTEIN TYROSINE PHOSPHATASE; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; RECEPTOR PROTEIN TYROSINE PHOSPHATASE; RECEPTOR PROTEIN TYROSINE PHOSPHATASE BETA; RECEPTOR PROTEIN TYROSINE PHOSPHATASE ZETA; SYNDECAN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

CANCER CELL; CANCER PROGNOSIS; CARCINOGENESIS; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; ENDOTHELIUM CELL; HUMAN; LEWIS CARCINOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR INVASION; TUMOR VASCULARIZATION;

ANGIOGENESIS; CELL MIGRATION; GLYCOSAMINOGLYCAN; GLYCOSYLATION; PROTEOGLYCAN; RECEPTOR PROTEIN TYROSINE PHOSPHATASE Β/Ζ;

ANIMALS; BLOOD VESSELS; CELL MEMBRANE; CELL MOVEMENT; CHONDROITIN SULFATES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS;

EID: 84903541517     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.01.009     Document Type: Review

References (136)

1. M.E. Janik, A. Litynska, and P. Vereecken Cell migration - the role of integrin glycosylation Biochim. Biophys. Acta 1800 2010 545 555
2. K. Furukawa, Y. Ohkawa, Y. Yamauchi, K. Hamamura, and Y. Ohmi Fine tuning of cell signals by glycosylation J. Biochem. 151 2012 573 578
3. J. Gu, T. Isaji, Q. Xu, Y. Kariya, W. Gu, T. Fukuda, and Y. Du Potential roles of N-glycosylation in cell adhesion Glycoconj. J. 29 2012 599 607
4. K. Ohtsubo, and J.D. Marth Glycosylation in cellular mechanisms of health and disease Cell 126 2006 855 867
5. T. Hennet Diseases of glycosylation beyond classical congenital disorders of glycosylation Biochim. Biophys. Acta 1820 2012 1306 1317
6. F. Muntoni, S. Torelli, D.J. Wells, and S.C. Brown Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies Curr. Opin. Neurol. 24 2011 437 442
7. J. Jaeken Congenital disorders of glycosylation (CDG): it's (nearly) all in it! J. Inherit. Metab. Dis. 34 2011 853 858
8. B. Xia, W. Zhang, X. Li, R. Jiang, T. Harper, R. Liu, R.D. Cummings, and M. He Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation Anal. Biochem. 442 2013 178 185
9. H.H. Freeze Genetic defects in the human glycome Nat. Rev. Genet. 7 2006 537 551
10. C.A. Reis, H. Osorio, L. Silva, C. Gomes, and L. David Alterations in glycosylation as biomarkers for cancer detection J. Clin. Pathol. 63 2010 322 329
11. J.G. Kang, J.H. Ko, and Y.S. Kim Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer BMB Rep. 44 2011 765 771
12. M. Li, L. Song, and X. Qin Glycan changes: cancer metastasis and anti-cancer vaccines J. Biosci. 35 2010 665 673
13. A. Varki, R. Kannagi, and B.P. Toole Glycosylation changes in cancer A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler, Essentials of Glycobiology 2009 Cold Spring Harbor Laboratory Press New York (Chapter 44)
14. N. Afratis, C. Gialeli, D. Nikitovic, T. Tsegenidis, E. Karousou, A.D. Theocharis, M.S. Pavao, G.N. Tzanakakis, and N.K. Karamanos Glycosaminoglycans: key players in cancer cell biology and treatment FEBS J. 279 2012 1177 1197
15. A. Varki, and J.D. Marth Oligosaccharides in vertebrate development Semin. Dev. Biol. 6 1995 127 138
16. C.D. Nandini, and K. Sugahara Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors Adv. Pharmacol. 53 2006 253 279
17. M. Shibuya Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases J. Biochem. 153 2013 13 19
18. T. Takahashi, and M. Shibuya The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts Oncogene 14 1997 2079 2089
19. A.I. Markowska, K.C. Jefferies, and N. Panjwani Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells J. Biol. Chem. 286 2011 29913 29921
20. T. Cohen, H. Gitay-Goren, R. Sharon, M. Shibuya, R. Halaban, B.Z. Levi, and G. Neufeld VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells J. Biol. Chem. 270 1995 11322 11326
21. B.A. Nacev, P. Grassi, A. Dell, S.M. Haslam, and J.O. Liu The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells J. Biol. Chem. 286 2011 44045 44056
22. E.A. Partridge, C. Le Roy, G.M. Di Guglielmo, J. Pawling, P. Cheung, M. Granovsky, I.R. Nabi, J.L. Wrana, and J.W. Dennis Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis Science 306 2004 120 124
23. Y.Y. Zhao, M. Takahashi, J.G. Gu, E. Miyoshi, A. Matsumoto, S. Kitazume, and N. Taniguchi Functional roles of N-glycans in cell signaling and cell adhesion in cancer Cancer Sci. 99 2008 1304 1310
24. P. Stanley, and T. Okajima Roles of glycosylation in Notch signaling Curr. Top. Dev. Biol. 92 2010 131 164
25. T. Watanabe, H. Tsuge, T. Imagawa, D. Kise, K. Hirano, M. Beppu, A. Takahashi, K. Yamaguchi, H. Fujiki, and M. Suganuma Nucleolin as cell surface receptor for tumor necrosis factor-α inducing protein: a carcinogenic factor of Helicobacter pylori J. Cancer Res. Clin. Oncol. 136 2010 911 921
26. M. Koutsioumpa, G. Drosou, C. Mikelis, K. Theochari, D. Vourtsis, P. Katsoris, E. Giannopoulou, J. Courty, C. Petrou, V. Magafa, P. Cordopatis, and E. Papadimitriou Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin Vasc. Cell 4 2012 4
27. M. Koutsioumpa, E. Poimenidi, C. Theodoropoulou, and E. Papadimitriou Receptor protein tyrosine phosphatase beta/zeta is a regulator of vascular endothelial growth factor-induced endothelial cell migration, 4th FEBS Advanced Lecture Course, "Matrix Pathobiology, Signaling and Molecular Targets", Kos 2013
28. E.A. Said, B. Krust, S. Nisole, J. Svab, J.P. Briand, and A.G. Hovanessian The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor J. Biol. Chem. 277 2002 37492 37502
29. E.M. Reyes-Reyes, and S.K. Akiyama Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells Exp. Cell Res. 314 2008 2212 2223
30. H. Shi, Y. Huang, H. Zhou, X. Song, S. Yuan, Y. Fu, and Y. Luo Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin Blood 110 2007 2899 2906
31. D. Destouches, D. El Khoury, Y. Hamma-Kourbali, B. Krust, P. Albanese, P. Katsoris, G. Guichard, J.P. Briand, J. Courty, and A.G. Hovanessian Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin PLoS One 3 2008 e2518
32. M. Carpentier, W. Morelle, B. Coddeville, A. Pons, M. Masson, J. Mazurier, and D. Legrand Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell compartment Biochemistry 44 2005 5804 5815
33. S. Aldi, C. Della Giovampaola, R. Focarelli, A. Armini, M. Ziche, F. Finetti, and F. Rosati A fucose-containing O-glycoepitope on bovine and human nucleolin Glycobiology 19 2009 337 343
34. M.E. Losfeld, D.E. Khoury, P. Mariot, M. Carpentier, B. Krust, J.P. Briand, J. Mazurier, A.G. Hovanessian, and D. Legrand The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells Exp. Cell Res. 315 2009 357 369
35. A.G. Hovanessian, F. Puvion-Dutilleul, S. Nisole, J. Svab, E. Perret, J.S. Deng, and B. Krust The cell-surface-expressed nucleolin is associated with the actin cytoskeleton Exp. Cell Res. 261 2000 312 328
36. M.E. Losfeld, A. Leroy, B. Coddeville, M. Carpentier, J. Mazurier, and D. Legrand N-Glycosylation influences the structure and self-association abilities of recombinant nucleolin FEBS J. 278 2011 2552 2564
37. R. Galzio, F. Rosati, E. Benedetti, L. Cristiano, S. Aldi, S. Mei, B. D'Angelo, R. Gentile, G. Laurenti, M.G. Cifone, A. Giordano, and A. Cimini Glycosilated nucleolin as marker for human gliomas J. Cell. Biochem. 113 2012 571 579
38. M.J. Kwon, B. Jang, J.Y. Yi, I.O. Han, and E.S. Oh Syndecans play dual roles as cell adhesion receptors and docking receptors FEBS Lett. 586 2012 2207 2211
39. Y. Choi, H. Chung, H. Jung, J.R. Couchman, and E.S. Oh Syndecans as cell surface receptors: unique structure equates with functional diversity Matrix Biol. 30 2011 93 99
40. E. Tkachenko, J.M. Rhodes, and M. Simons Syndecans: new kids on the signaling block Circ. Res. 96 2005 488 500
41. T. Kinnunen, M. Kaksonen, J. Saarinen, N. Kalkkinen, H.B. Peng, and H. Rauvala Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth J. Biol. Chem. 273 1998 10702 10708
42. S. Imai, M. Kaksonen, E. Raulo, T. Kinnunen, C. Fages, X. Meng, M. Lakso, and H. Rauvala Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM) J. Cell Biol. 143 1998 1113 1128
43. M. Salmivirta, K. Elenius, S. Vainio, U. Hofer, R. Chiquet-Ehrismann, I. Thesleff, and M. Jalkanen Syndecan from embryonic tooth mesenchyme binds tenascin J. Biol. Chem. 266 1991 7733 7739
44. R. Kokenyesi, and M. Bernfield Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1 J. Biol. Chem. 269 1994 12304 12309
45. M. Ueno, S. Yamada, M. Zako, M. Bernfield, and K. Sugahara Structural characterization of heparan sulfate and chondroitin sulfate of syndecan-1 purified from normal murine mammary gland epithelial cells. Common phosphorylation of xylose and differential sulfation of galactose in the protein linkage region tetrasaccharide sequence J. Biol. Chem. 276 2001 29134 29140
46. S.S. Deepa, S. Yamada, M. Zako, O. Goldberger, and K. Sugahara Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor J. Biol. Chem. 279 2004 37368 37376
47. C. Mikelis, M. Koutsioumpa, and E. Papadimitriou Pleiotrophin as a possible new target for angiogenesis-related diseases and cancer Recent Pat. Anticancer Drug Discov. 2 2007 175 186
48. E. Papadimitriou, C. Mikelis, E. Lampropoulou, M. Koutsioumpa, K. Theochari, S. Tsirmoula, C. Theodoropoulou, M. Lamprou, E. Sfaelou, D. Vourtsis, and P. Boudouris Roles of pleiotrophin in tumor growth and angiogenesis Eur. Cytokine Netw. 20 2009 180 190
49. N. Maeda, K. Ichihara-Tanaka, T. Kimura, K. Kadomatsu, T. Muramatsu, and M. Noda A receptor-like protein-tyrosine phosphatase PTPζ/RPTPβ binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPζ J. Biol. Chem. 274 1999 12474 12479
50. C. Ueoka, N. Kaneda, I. Okazaki, S. Nadanaka, T. Muramatsu, and K. Sugahara Neuronal cell adhesion, mediated by the heparin-binding neuroregulatory factor midkine, is specifically inhibited by chondroitin sulfate E. Structural and functional implications of the over-sulfated chondroitin sulfate J. Biol. Chem. 275 2000 37407 37413
51. S.S. Deepa, Y. Umehara, S. Higashiyama, N. Itoh, and K. Sugahara Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues J. Biol. Chem. 277 2002 43707 43716
52. N. Maeda, T. Nishiwaki, T. Shintani, H. Hamanaka, and M. Noda 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase ζ/RPTPβ, binds pleiotrophin/heparin- binding growth-associated molecule (HB-GAM) J. Biol. Chem. 271 1996 21446 21452
53. O. Okamoto, S. Bachy, U. Odenthal, J. Bernaud, D. Rigal, H. Lortat-Jacob, N. Smyth, and P. Rousselle Normal human keratinocytes bind to the α3LG4/5 domain of unprocessed laminin-5 through the receptor syndecan-1 J. Biol. Chem. 278 2003 44168 44177
54. B. Chanana, P. Steigemann, H. Jackle, and G. Vorbruggen Reception of Slit requires only the chondroitin-sulphate-modified extracellular domain of syndecan at the target cell surface Proc. Natl. Acad. Sci. U. S. A. 106 2009 11984 11988
55. M.A. Burg, A. Nishiyama, and W.B. Stallcup A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen Exp. Cell Res. 235 1997 254 264
56. 1 integrin Mol. Biol. Cell 15 2004 3580 3590
57. W.K. You, F. Yotsumoto, K. Sakimura, R.H. Adams, and W.B. Stallcup NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function Angiogenesis 17 2014 61 76
58. W.B. Stallcup, and F.J. Huang A role for the NG2 proteoglycan in glioma progression Cell Adhes. Migr. 2 2008 192 201
59. J. Wang, A. Svendsen, J. Kmiecik, H. Immervoll, K.O. Skaftnesmo, J. Planaguma, R.K. Reed, R. Bjerkvig, H. Miletic, P.O. Enger, C.B. Rygh, and M. Chekenya Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma PLoS One 6 2011 e23062
60. S. Cattaruzza, U. Ozerdem, M. Denzel, B. Ranscht, P. Bulian, U. Cavallaro, D. Zanocco, A. Colombatti, W.B. Stallcup, and R. Perris Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells Angiogenesis 16 2013 309 327
61. F. Lopez-Casillas, H.M. Payne, J.L. Andres, and J. Massague Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: mapping of ligand binding and GAG attachment sites J. Cell Biol. 124 1994 557 568
62. M. Bilandzic, and K.L. Stenvers Betaglycan: a multifunctional accessory Mol. Cell. Endocrinol. 339 2011 180 189
63. J.L. Andres, D. DeFalcis, M. Noda, and J. Massague Binding of two growth factor families to separate domains of the proteoglycan betaglycan J. Biol. Chem. 267 1992 5927 5930
64. M.W. Parker, H.F. Guo, X. Li, A.D. Linkugel, and C.W. Vander Kooi Function of members of the neuropilin family as essential pleiotropic cell surface receptors Biochemistry 51 2012 9437 9446
65. A.L. Kolodkin, D.V. Levengood, E.G. Rowe, Y.T. Tai, R.J. Giger, and D.D. Ginty Neuropilin is a semaphorin III receptor Cell 90 1997 753 762
66. S. Soker, S. Takashima, H.Q. Miao, G. Neufeld, and M. Klagsbrun Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor Cell 92 1998 735 745
67. Y. Shintani, S. Takashima, Y. Asano, H. Kato, Y. Liao, S. Yamazaki, O. Tsukamoto, O. Seguchi, H. Yamamoto, T. Fukushima, K. Sugahara, M. Kitakaze, and M. Hori Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling EMBO J. 25 2006 3045 3055
68. P. Frankel, C. Pellet-Many, P. Lehtolainen, G.M. D'Abaco, M.L. Tickner, L. Cheng, and I.C. Zachary Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas-mediated pathway EMBO Rep. 9 2008 983 989
69. C. Pellet-Many, P. Frankel, I.M. Evans, B. Herzog, M. Junemann-Ramirez, and I.C. Zachary Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas Biochem. J. 435 2011 609 618
70. G. Dick, C.L. Tan, J.N. Alves, E.M. Ehlert, G.M. Miller, L.C. Hsieh-Wilson, K. Sugahara, A. Oosterhof, T.H. van Kuppevelt, J. Verhaagen, J.W. Fawcett, and J.C. Kwok Semaphorin 3A binds to the perineuronal nets via chondroitin sulfate type E motifs in rodent brains J. Biol. Chem. 288 2013 27384 27395
71. S. Cabodi, P. Di Stefano, P. Leal Mdel, A. Tinnirello, B. Bisaro, V. Morello, L. Damiano, S. Aramu, D. Repetto, G. Tornillo, and P. Defilippi Integrins and signal transduction Adv. Exp. Med. Biol. 674 2010 43 54
72. A. Huttenlocher, and A.R. Horwitz Integrins in cell migration Cold Spring Harb. Perspect Biol. 3 2011 a005074
73. G.C. Alghisi, and C. Ruegg Vascular integrins in tumor angiogenesis: mediators and therapeutic targets Endothelium 13 2006 113 135
74. W. Cai, G. Niu, and X. Chen Imaging of integrins as biomarkers for tumor angiogenesis Curr. Pharm. Des. 14 2008 2943 2973
75. S.D. Robinson, and K.M. Hodivala-Dilke The role of β3-integrins in tumor angiogenesis: context is everything Curr. Opin. Cell Biol. 23 2011 630 637
76. 1 integrin is a facultative proteoglycan J. Biol. Chem. 272 1997 12529 12535
77. 1 integrin are involved in fibronectin-dependent cell migration Biochem. Cell Biol. 87 2009 677 686
78. 3 integrin activity in human mammary carcinoma cells J. Cell Biol. 167 2004 171 181
79. 5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor J. Exp. Med. 206 2009 691 705
80. 3 integrin that activates PKCα and RhoA J. Cell Sci. 122 2009 3462 3471
81. M. Koutsioumpa, and E. Papadimitriou PG receptors with phosphatase action in cancer and angiogenesis N. Karamanos, Extracellular Matrix: Pathobiology and Signalling 2012 813 823
82. A.N. Mohebiany, R.M. Nikolaienko, S. Bouyain, and S. Harroch Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack FEBS J. 280 2013 388 400
83. G. Daum, S. Regenass, J. Sap, J. Schlessinger, and E.H. Fischer Multiple forms of the human tyrosine phosphatase RPTPα. Isozymes and differences in glycosylation J. Biol. Chem. 269 1994 10524 10528
84. H. Honda, J. Inazawa, J. Nishida, Y. Yazaki, and H. Hirai Molecular cloning, characterization, and chromosomal localization of a novel protein-tyrosine phosphatase, HPTP eta Blood 84 1994 4186 4194
85. C. Wang, Y. Yang, Z. Yang, M. Liu, Z. Li, L. Sun, C. Mei, H. Chen, L. Chen, L. Wang, and X. Zha EGF-mediated migration signaling activated by N-acetylglucosaminyltransferase-V via receptor protein tyrosine phosphatase kappa Arch. Biochem. Biophys. 486 2009 64 72
86. O. Suzuki, Y. Nozawa, and M. Abe Regulatory roles of altered N- and O-glycosylation of CD45 in galectin-1-induced cell death in human diffuse large B cell lymphoma Int. J. Oncol. 26 2005 1063 1068
87. G. Barnea, M. Grumet, P. Milev, O. Silvennoinen, J.B. Levy, J. Sap, and J. Schlessinger Receptor tyrosine phosphatase β is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin J. Biol. Chem. 269 1994 14349 14352
88. P.N. Chien, and S.E. Ryu Protein tyrosine phosphatase σ in proteoglycan-mediated neural regeneration regulation Mol. Neurobiol. 47 2013 220 227
89. R.T. Gardner, and B.A. Habecker Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injury J. Neurosci. 33 2013 7175 7183
90. C.H. Coles, Y. Shen, A.P. Tenney, C. Siebold, G.C. Sutton, W. Lu, J.T. Gallagher, E.Y. Jones, J.G. Flanagan, and A.R. Aricescu Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension Science 332 2011 484 488
91. J.C. Pendleton, M.J. Shamblott, D.S. Gary, V. Belegu, A. Hurtado, M.L. Malone, and J.W. McDonald Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ Exp. Neurol. 247 2013 113 121
92. Y. Shen, A.P. Tenney, S.A. Busch, K.P. Horn, F.X. Cuascut, K. Liu, Z. He, J. Silver, and J.G. Flanagan PTPσ is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration Science 326 2009 592 596
93. J.M. Brown, J. Xia, B. Zhuang, K.S. Cho, C.J. Rogers, C.I. Gama, M. Rawat, S.E. Tully, N. Uetani, D.E. Mason, M.L. Tremblay, E.C. Peters, O. Habuchi, D.F. Chen, and L.C. Hsieh-Wilson A sulfated carbohydrate epitope inhibits axon regeneration after injury Proc. Natl. Acad. Sci. U. S. A. 109 2012 4768 4773
94. D. Fisher, B. Xing, J. Dill, H. Li, H.H. Hoang, Z. Zhao, X.L. Yang, R. Bachoo, S. Cannon, F.M. Longo, M. Sheng, J. Silver, and S. Li Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors J. Neurosci. 31 2011 14051 14066
95. D.E. Alete, M.E. Weeks, A.G. Hovanession, M. Hawadle, and A.W. Stoker Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor PTPσ FEBS J. 273 2006 4668 4681
96. P. Maurel, U. Rauch, M. Flad, R.K. Margolis, and R.U. Margolis Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase Proc. Natl. Acad. Sci. U. S. A. 91 1994 2512 2516
97. A. Fujikawa, D. Shirasaka, S. Yamamoto, H. Ota, K. Yahiro, M. Fukada, T. Shintani, A. Wada, N. Aoyama, T. Hirayama, H. Fukamachi, and M. Noda Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori Nat. Genet. 33 2003 375 381
98. U. Rauch, P. Gao, A. Janetzko, A. Flaccus, L. Hilgenberg, H. Tekotte, R.K. Margolis, and R.U. Margolis Isolation and characterization of developmentally regulated chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of brain identified with monoclonal antibodies J. Biol. Chem. 266 1991 14785 14801
99. A.M. Clement, S. Nadanaka, K. Masayama, C. Mandl, K. Sugahara, and A. Faissner The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth J. Biol. Chem. 273 1998 28444 28453
100. N. Maeda, J. He, Y. Yajima, T. Mikami, K. Sugahara, and T. Yabe Heterogeneity of the chondroitin sulfate portion of phosphacan/6B4 proteoglycan regulates its binding affinity for pleiotrophin/heparin binding growth-associated molecule J. Biol. Chem. 278 2003 35805 35811
101. K.L. Abbott, R.T. Matthews, and M. Pierce Receptor tyrosine phosphatase β (RPTPβ) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding J. Biol. Chem. 283 2008 33026 33035
102. C.A. Dwyer, E. Baker, H. Hu, and R.T. Matthews RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1 Neuroscience 220 2012 47 61
103. A. Polykratis, P. Katsoris, J. Courty, and E. Papadimitriou Characterization of heparin affin regulatory peptide signaling in human endothelial cells J. Biol. Chem. 280 2005 22454 22461
104. C. Polytarchou, M. Hatziapostolou, E. Poimenidi, C. Mikelis, A. Papadopoulou, A. Parthymou, and E. Papadimitriou Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase β/ζ Int. J. Cancer 124 2009 1785 1793
105. S. Muller, P. Kunkel, K. Lamszus, U. Ulbricht, G.A. Lorente, A.M. Nelson, D. von Schack, D.J. Chin, S.C. Lohr, M. Westphal, and T. Melcher A role for receptor tyrosine phosphataseζ in glioma cell migration Oncogene 22 2003 6661 6668
106. 3 is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase β/ζ FASEB J. 23 2009 1459 1469
107. E. Peles, M. Nativ, P.L. Campbell, T. Sakurai, R. Martinez, S. Lev, D.O. Clary, J. Schilling, G. Barnea, G.D. Plowman, M. Grumet, and J. Schlessinger The carbonic anhydrase domain of receptor tyrosine phosphatase β is a functional ligand for the axonal cell recognition molecule contactin Cell 82 1995 251 260
108. J. den Hertog, A. Ostman, and F.D. Bohmer Protein tyrosine phosphatases: regulatory mechanisms FEBS J. 275 2008 831 847
109. F. Bohmer, S. Szedlacsek, L. Tabernero, A. Ostman, and J. den Hertog Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis FEBS J. 280 2013 413 431
110. D. Thomaidou, D. Coquillat, S. Meintanis, M. Noda, G. Rougon, and R. Matsas Soluble forms of NCAM and F3 neuronal cell adhesion molecules promote Schwann cell migration: identification of protein tyrosine phosphatases ζ/β as the putative F3 receptors on Schwann cells J. Neurochem. 78 2001 767 778
111. U. Ulbricht, C. Eckerich, R. Fillbrandt, M. Westphal, and K. Lamszus RNA interference targeting protein tyrosine phosphatase ζ/receptor-type protein tyrosine phosphatase β suppresses glioblastoma growth in vitro and in vivo J. Neurochem. 98 2006 1497 1506
112. K.V. Lu, K.A. Jong, G.Y. Kim, J. Singh, E.Q. Dia, K. Yoshimoto, M.Y. Wang, T.F. Cloughesy, S.F. Nelson, and P.S. Mischel Differential induction of glioblastoma migration and growth by two forms of pleiotrophin J. Biol. Chem. 280 2005 26953 26964
113. N. Maeda, and M. Noda Involvement of receptor-like protein tyrosine phosphatase ζ/RPTPβ and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration J. Cell Biol. 142 1998 203 216
114. N. Sakaguchi, H. Muramatsu, K. Ichihara-Tanaka, N. Maeda, M. Noda, T. Yamamoto, M. Michikawa, S. Ikematsu, S. Sakuma, and T. Muramatsu Receptor-type protein tyrosine phosphatase ζ as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons Neurosci. Res. 45 2003 219 224
115. S. Cohen, O.Y. Shoshana, E. Zelman-Toister, N. Maharshak, I. Binsky-Ehrenreich, M. Gordin, I. Hazan-Halevy, Y. Herishanu, L. Shvidel, M. Haran, L. Leng, R. Bucala, S. Harroch, and I. Shachar The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74 J. Immunol. 188 2012 259 269
116. K. Kadomatsu, and T. Muramatsu Midkine and pleiotrophin in neural development and cancer Cancer Lett. 204 2004 127 143
117. S. Nandi, M. Cioce, Y.G. Yeung, E. Nieves, L. Tesfa, H. Lin, A.W. Hsu, R. Halenbeck, H.Y. Cheng, S. Gokhan, M.F. Mehler, and E.R. Stanley Receptor-type protein tyrosine phosphatase ζ is a functional receptor for interleukin-34 J. Biol. Chem. 288 2013 21972 21986
118. M. Tanaka, N. Maeda, M. Noda, and T. Marunouchi A chondroitin sulfate proteoglycan PTPζ/RPTPβ regulates the morphogenesis of Purkinje cell dendrites in the developing cerebellum J. Neurosci. 23 2003 2804 2814
119. K. Meng, A. Rodriguez-Pena, T. Dimitrov, W. Chen, M. Yamin, M. Noda, and T.F. Deuel Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase β/ζ Proc. Natl. Acad. Sci. U. S. A. 97 2000 2603 2608
120. M. Fukada, A. Fujikawa, J.P. Chow, S. Ikematsu, S. Sakuma, and M. Noda Protein tyrosine phosphatase receptor type Z is inactivated by ligand-induced oligomerization FEBS Lett. 580 2006 4051 4056
121. H. Pariser, P. Perez-Pinera, L. Ezquerra, G. Herradon, and T.F. Deuel Pleiotrophin stimulates tyrosine phosphorylation of β-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase β/ζ Biochem. Biophys. Res. Commun. 335 2005 232 239
122. H. Pariser, L. Ezquerra, G. Herradon, P. Perez-Pinera, and T.F. Deuel Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase β/ζ-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin Biochem. Biophys. Res. Commun. 332 2005 664 669
123. C. Mikelis, M. Lamprou, M. Koutsioumpa, A.G. Koutsioubas, Z. Spyranti, A.A. Zompra, N. Spiliopoulos, A.A. Vradis, P. Katsoris, G.A. Spyroulias, P. Cordopatis, J. Courty, and E. Papadimitriou A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro J. Cell. Biochem. 112 2011 1532 1543
124. S.B. Gao, Z.J. Feng, B. Xu, Y. Chen, H.H. Zheng, P. Yin, X. Hua, and G.H. Jin Menin represses malignant phenotypes of melanoma through regulating multiple pathways J. Cell. Mol. Med. 15 2011 2353 2363
125. Z. Diamantopoulou, O. Bermek, A. Polykratis, Y. Hamma-Kourbali, J. Delbe, J. Courty, and P. Katsoris A pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPβ/ζ Mol. Cancer 9 2010 224
126. A. Hienola, S. Tumova, E. Kulesskiy, and H. Rauvala N-syndecan deficiency impairs neural migration in brain J. Cell Biol. 174 2006 569 580
127. H.A. Himburg, G.G. Muramoto, P. Daher, S.K. Meadows, J.L. Russell, P. Doan, J.T. Chi, A.B. Salter, W.E. Lento, T. Reya, N.J. Chao, and J.P. Chute Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells Nat. Med. 16 2010 475 482
128. B. Souttou, D. Raulais, and M. Vigny Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways J. Cell. Physiol. 187 2001 59 64
129. 3 integrin and nucleolin regulates human endothelial and glioma cell migration J. Biol. Chem. 288 2013 343 354
130. C.D. Nandini, T. Mikami, M. Ohta, N. Itoh, F. Akiyama-Nambu, and K. Sugahara Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish. Neuritogenic and binding activities for growth factors and neurotrophic factors J. Biol. Chem. 279 2004 50799 50809
131. G.B. ten Dam, E.M. van de Westerlo, A. Purushothaman, R.V. Stan, J. Bulten, F.C. Sweep, L.F. Massuger, K. Sugahara, and T.H. van Kuppevelt Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding Am. J. Pathol. 171 2007 1324 1333
132. T. Muramatsu Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis J. Biochem. 132 2002 359 371
133. M. Qi, S. Ikematsu, N. Maeda, K. Ichihara-Tanaka, S. Sakuma, M. Noda, T. Muramatsu, and K. Kadomatsu Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase ζ. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase J. Biol. Chem. 276 2001 15868 15875
134. S. Mizumoto, M. Watanabe, S. Yamada, and K. Sugahara Expression of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase involved in chondroitin sulfate synthesis is responsible for pulmonary metastasis Biomed. Res. Int. 2013 2013 656319
135. T. Kobayashi, H. Yan, Y. Kurahashi, Y. Ito, H. Maeda, T. Tada, K. Hongo, and J. Nakayama Role of GalNAc4S-6ST in astrocytic tumor progression PLoS One 8 2013 e54278
136. Basappa, S. Murugan, K.N. Sugahara, C.M. Lee, G.B. ten Dam, T.H. van Kuppevelt, M. Miyasaka, S. Yamada, and Sugahara Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells Glycobiology 19 2009 735 742